StonvexLoading…
StonvexStonvexStonvexCore line items from AVB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.83M | $7.04M | $5.20M | $3.34M |
Operating Income | $517.49M | $2.02B | $1.51B | $1.02B |
Net Income | $325.73M | $1.06B | $886.57M | $505.26M |
EPS (Diluted) | $2.33 | $7.40 | $6.22 | $3.54 |
Total Assets | $22.13B | $22.19B | $21.95B | $21.84B |
Total Liabilities | $10.41B | $10.36B | $9.79B | $9.67B |
Cash & Equivalents | $121.23M | $187.23M | $123.31M | $102.83M |
Free Cash Flow OCF − CapEx | $359.48M | $1.41B | $1.09B | $684.68M |
Shares Outstanding | 139.11M | 140.08M | 141.59M | 142.38M |